» Articles » PMID: 26918872

Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis

Overview
Journal Pancreas
Specialty Gastroenterology
Date 2016 Feb 27
PMID 26918872
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Diabetes mellitus is a frequent consequence of chronic pancreatitis (CP). Little is known about pancreatic endocrine function before the development of diabetes mellitus in CP, particularly in females, or those without calcific and/or alcoholic pancreatitis.

Methods: Twenty-five nondiabetic adult patients with CP (19 female; mean [SE] age, 34.2 [2.4] years) were compared with 25 healthy controls matched for age, sex, and body mass index. Subjects underwent frequent sample intravenous glucose tolerance testing (FSIVGTT) and mixed meal tolerance testing (MMTT).

Results: Mean (SE) fasting glucose was higher in patients with CP (89.5 [2.3] mg/dL) than in controls (84.4 [1.2] mg/dL, P = 0.04). On MMTT, patients with CP had a higher area under the curve (AUC) glucose and AUC glucagon compared with controls (P ≤ 0.01). The AUC C-peptide was equivalent (P = 0.6) but stimulated C-peptide at 30 minutes was lower in patients with CP (P = 0.04). Mean insulin sensitivity index calculated from the FSIVGTT was lower in CP group, indicating reduced insulin sensitivity (P ≤ 0.01). Disposition index (insulin secretion adjusted for insulin sensitivity on FSIVGTT) was lower in patients with CP (P = 0.01).

Conclusions: Patients with CP had higher fasting and MMTT glucose levels, without a compensatory increase in insulin secretion suggesting subtle early islet dysfunction. Our cohort had relative hyperglucagonemia and was less insulin sensitive than controls.

Citing Articles

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.


Risk Factors and Mechanisms for Diabetes in Pancreatitis.

Parra Villasmil M, Bellin M Gastroenterol Clin North Am. 2025; 54(1):175-188.

PMID: 39880526 PMC: 11780253. DOI: 10.1016/j.gtc.2024.08.002.


Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis.

Wlodarczyk B, Durko L, Walczak K, Talar-Wojnarowska R, Malecka-Wojciesko E Int J Mol Sci. 2024; 25(22).

PMID: 39596226 PMC: 11594802. DOI: 10.3390/ijms252212159.


Ductal Intervention in Chronic Pancreatitis: Impact on Glycemic Control and Endocrine Insufficiency Management.

Harindranath S, Patra B, Ansari A, Vaidya A, Singh A, Sundaram S Cureus. 2024; 16(8):e66378.

PMID: 39246884 PMC: 11379413. DOI: 10.7759/cureus.66378.


The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.

Taylor G, Smith K, Scragg J, McDonald T, Shaw J, West D Diabetologia. 2024; 67(7):1413-1428.

PMID: 38662134 PMC: 11153288. DOI: 10.1007/s00125-024-06153-0.


References
1.
Ewald N, Hardt P . Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol. 2013; 19(42):7276-81. PMC: 3831209. DOI: 10.3748/wjg.v19.i42.7276. View

2.
Schrader H, Menge B, Zeidler C, Ritter P, Tannapfel A, Uhl W . Determinants of glucose control in patients with chronic pancreatitis. Diabetologia. 2010; 53(6):1062-9. DOI: 10.1007/s00125-010-1705-0. View

3.
Moran A, Diem P, Klein D, Levitt M, Robertson R . Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991; 118(5):715-23. DOI: 10.1016/s0022-3476(05)80032-0. View

4.
Howes N, Lerch M, Greenhalf W, Stocken D, Ellis I, Simon P . Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004; 2(3):252-61. DOI: 10.1016/s1542-3565(04)00013-8. View

5.
Nyboe Andersen B, Krarup T, Thorsgaard Pedersen N, Faber O, Hagen C, Worning H . B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia. 1982; 23(2):86-9. DOI: 10.1007/BF01271165. View